GT-2203

GT-2203
Clinical data
Other names	VUF-5296; (1R,2R)-Cyclopropylhistamine; (1R,2R)-trans-2-(1H-imidazol-4-yl)cyclopropylamine
Routes of; administration	Unspecified
Drug class	Histamine H3 receptor agonist
ATC code	None;
Identifiers
	IUPAC name trans-(1R,2R)-2-(1H-imidazol-5-yl)cyclopropan-1-amine;
CAS Number	186194-74-1;
PubChem CID	10103168;
ChemSpider	8278696;
ChEMBL	ChEMBL13559;
Chemical and physical data
Formula	C6H9N3
Molar mass	123.159 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1[C@H]([C@@H]1N)C2=CN=CN2;
	InChI InChI=1S/C6H9N3/c7-5-1-4(5)6-2-8-3-9-6/h2-5H,1,7H2,(H,8,9)/t4-,5-/m1/s1; Key:OWWNABDDYQLERE-RFZPGFLSSA-N;

GT-2203, also known as VUF-5296, (1R,2R)-cyclopropylhistamine, or (1R,2R)-trans-2-(1H-imidazol-4-yl)cyclopropylamine, is a histamine H₃ receptor agonist which was under development for the treatment of insomnia and anxiety disorders but was never marketed. Its route of administration was unspecified.